Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
D-alanyl-D-alanine carboxypeptidase DacB (PBP4) is an enzyme crucial for bacterial cell wall biogenesis. It functions as a DD-carboxypeptidase and DD-endopeptidase, removing C-terminal D-alanyl residues from peptidoglycan precursors. This activity is essential for proper peptidoglycan maturation and regulation of cross-linking within the bacterial cell wall. DacB is a penicillin-binding protein and a target for antibacterial drug development.
Inhibition of DD-carboxypeptidase activity, leading to disruption of peptidoglycan synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-alanyl-D-alanine carboxypeptidase DacB (DacB).